Oakbrook Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Oakbrook Investments’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,950	Closed	-$510K	–	609
2015 Q1	$510K	Sell	2,950 -2,350	-44%	-$345K	0.03%	389
2014 Q4	$609K	Buy	+5,300	New	+$642K	0.03%	342
2014 Q1	–	Sell	-5,700	Closed	-$513K	–	652
2013 Q4	$513K	Buy	5,700 +2,400	+73%	+$191K	0.01%	407
2013 Q3	$221K	Buy	+3,300	New	+$227K	0.01%	552

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Oakbrook Investments's SLXP Position: Q2 2015 in Review

Oakbrook Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,950 shares — an estimated $510K sold.

Oakbrook Investments first reported a position in SLXP in Q3 2013 and held it in 4 quarters. The position peaked at $609K in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Oakbrook Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Oakbrook Investments sold 2,950 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $510K.
Oakbrook Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 4 quarters.
Oakbrook Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $609K in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Oakbrook Investments's 13F filing for Q2 2015, filed 16 Jul 2015.